Form D · Biotechnology

Lab7 Systems, Inc.

Austin, TX · CIK 0001553175

Offering snapshot reported Nov 3, 2016 · SEC filing

Reported sold
$1.5M
Offering amount: $1.5M
Investors reported
1
Form D · investor count
Minimum accepted
$1.5M
Reported outside-investor minimum
First sale
Oct 26, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 3, 2016Initial$1,500,000No comparison1SEC filing
Jun 21, 2016Amendment$215,000$5,000vs Jul 15, 20143SEC filing
Jun 21, 2016Initial$250,000No comparison1SEC filing
Jul 15, 2014Amendment$210,000$55,000vs Dec 30, 20133SEC filing
Dec 30, 2013Amendment$155,000$70,000vs Dec 30, 20133SEC filing
Dec 30, 2013Amendment$85,000$25,000vs Jul 9, 20133SEC filing
Nov 8, 2013Amendment$130,000$70,000vs Jul 9, 20138SEC filing
Jul 9, 2013Initial$60,000No comparison3SEC filing
Mar 29, 2013Amendment$500,000$290,000vs Jun 29, 201216SEC filing
Jan 28, 2013Amendment$465,000$255,000vs Jun 29, 201214SEC filing
Jun 29, 2012Initial$210,000No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-273735

Source: Form D, filed Nov 3, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christopher Mueller Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3101 Beverly Road
Austin, TX, 78703